ArticleACS omega2025
Computational Insight into the Intercalating Properties of Cryptolepine.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA is held together by hydrogen bonding between nucleobases (adenine-thymine, guanine-cytosine) and van der Waals interactions between adjacent base pairs' π orbitals. Intercalating molecules with quasiplanar structures utilize van der Waals interactions to bind between DNA base pairs. Experimental studies have shown that Cryptolepine preferentially intercalates between nonalternating cytosine and guanine base pairs. However, an atomic-scale mechanism that can explain the selective intercalation is still missing. Using molecular dynamics and density functional theory, we demonstrate how Cryptolepine binds to DNA base pairs, rationalizing its selectivity by analyzing the intermolecular bonding strength predicted by Umbrella Sampling and Free Energy Perturbation calculations. Cryptolepine is stable in all DNA base conformations studied, and the binding is a combination of van der Waals interactions with the nucleobases surrounding its π system and hydrogen bonds with the DNA backbone and nucleobases. Our model predicts a preference for cytosine and guanine base pairs with a more prominent preference for alternating cytosine and guanine base pairs. These findings illustrate Cryptolepine's binding mechanism to DNA and highlight the importance of hydrogen bonds and van der Waals interactions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.